Immix Biopharma, Inc.IMMXNASDAQ
Loading
EBITDA Over TimeContracting
Percentile Rank17
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$-23.69M
↓ 73% vs avg
Percentile
P17
Within normal range
Streak
3 yr
Consecutive declineContracting
Average
$-13.73M
Historical baseline
PeriodValueYoY Change
TTM$-23.69M-5.0%
2024$-22.56M-39.8%
2023$-16.14M-96.4%
2022$-8.22M+66.0%
2021$-24.20M-5258.6%
2020$-451531.00+46.3%
2019$-841417.00-